Previous 10 | Next 10 |
Elanco Animal Health (NYSE:ELAN) expands its shared value footprint across Sub-Saharan Africa, delivering on its 2030 pledge to create sustainable development solutions for those who depend on livestock for their livelihoods. Company commits to bringing its comprehensive product portfoli...
Elanco Animal Health Incorporated (ELAN: NYSE) today announces the expansion of its shared value footprint across Sub-Saharan Africa, delivering on its 2030 pledge to create sustainable development solutions for those who depend on livestock for their livelihoods. This press release...
Animal health companies Elanco Animal Health (ELAN -0.2%), IDEXX Laboratories (IDXX -0.4%) and Zoetis (ZTS -2.3%) have continued their recent losses on Tuesday as the U.S. deals with a rising number of avian flu outbreaks. After detections among waterfowl in mid-January along the eastern seab...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Bank of America screened for stocks that could benefit from 10 scarcity themes, ranging from freshwater to increasing healthcare demands from an aging population. All the stocks have Buy ratings from their respective analysts. "We believe the current global resource supply vs. demand imbalanc...
Image source: The Motley Fool. Elanco Animal Health Inc. (NYSE: ELAN) Q4 2021 Earnings Call Feb 24, 2022 , 8:00 a.m. ET Operator Continue reading For further details see: Elanco Animal Health Inc. (ELAN) Q4 2021 Earnings Call Transcript ...
Elanco Animal Health Incorporated (ELAN) Q4 2021 Earnings Conference Call February 24, 2022 08:30 AM ET Company Participants Katy Grissom - Head of IR Jeff Simmons - CEO Todd Young - CFO Ellen de Brabander - EVP of Innovation and Regulatory Affairs Scott Purucker - IR Conference Call Particip...
The following slide deck was published by Elanco Animal Health Incorporated in conjunction with their 2021 Q4 earnings call. For further details see: Elanco Animal Health Incorporated 2021 Q4 - Results - Earnings Call Presentation
Elanco press release (NYSE:ELAN): Q4 Non-GAAP EPS of $0.21 beats by $0.04. Revenue of $1.11B (-2.6% Y/Y) beats by $10M. FY22 Guidance: Providing financial guidance for the full year 2022 with revenue of $4,745 to $4,800 million vs. $4.85B consensus, representing growth on a reported basis at ...
Full year 2021 revenue was $4,765 million, an increase of 46 percent, including $1,311 million of incremental revenue from Bayer Animal Health products in 2021. Full year 2021 earnings per share (EPS) was $(0.97) (reported), or $1.05 (adjusted). Fourth quarter 2021 rev...
News, Short Squeeze, Breakout and More Instantly...
Elanco Animal Health Incorporated Company Name:
ELAN Stock Symbol:
NYSE Market:
Elanco Animal Health Incorporated Website:
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / Feeding dairy cows Bovaer® (3-NOP), Elanco's newest feed ingredient , provides a scalable and credible way for dairy farmers to benefit from being good stewards of the environment by being financially rewarded for implementing on-farm sustaina...
Elanco Confirms Date and Conference Call for Second Quarter 2024 Financial Results Announcement PR Newswire GREENFIELD, Ind. , July 18, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its second quarter 2024 financial results on ...
SAN FRANCISCO, CA / ACCESSWIRE / July 17, 2024 / Hagens Berman urges Elanco Animal Health Incorporated (NYSE:ELAN) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/elan Contact the Firm Now: ELAN@hbsslaw.com 844-916-0895 ...